Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...

The North Chicago drugmaker says it could pay Xilio Therapeutics more than $2.1 billion in a collaboration and ...

Q3 2025 Management View CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% ...

The Hollings Cancer Network (HCN) and Tidelands Health announced on Monday that there will be expanded oncology services to ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

While AI can improve efficiency and accuracy, Patt warns of risks such as bias and data fabrication, stressing that the technology must be integrated thoughtfully alongside clinicians, and calls for ...

Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Kura Oncology in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst ...

Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss which populations are seen as the most underrepresented in oncology clinical trials.

Stock analysts at Wedbush issued their FY2029 earnings estimates for Kura Oncology in a note issued to investors on Thursday, February 6th. Wedbush analyst R. Driscoll expects that the company will ...

Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based ...

San Diego, CA — February 12, 2025 — Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has ...